New Guidance for Treating Systemic Sclerosis-associated ILD
A new ATS clinical practice guideline recommends expanding antifibrotic treatment to all patients with systemic sclerosis associated with ILD, not just those with progressive disease.
Tag: nintedanib
New Guidance for Treating Systemic Sclerosis-associated ILD
A new ATS clinical practice guideline recommends expanding antifibrotic treatment to all patients with systemic sclerosis associated with ILD, not just those with progressive disease.
Read More
Study: Nintedanib for Idiopathic Pulmonary Fibrosis
A study in the journal Respiration showed that patients with idiopathic pulmonary fibrosis who were treated with nintedanib saw more positive outcomes.
Read More